IDH1 and central nervous system cancer: Another indicator of unusual metabolic reprogramming in mutant IDH1 gliomas is their silencing of LDHA expression shown by Chesnelong et al. to occur via promoter hypermethylation in patient-derived mutant IDH1 glioma models and patient samples [26].